BELLEVUE, Wash.--(BUSINESS WIRE)--April 21, 2006--SCOLR Pharma, Inc (AMEX: DDD - News) today announced it has closed its previously reported registered direct offering of 2,370,100 shares of common stock at a price of $5.00 per share. The aggregate gross proceeds from the direct offering were approximately $11,850,500. The net proceeds, after deducting the placement agents' fee and other estimated offering expenses, were approximately $10.9 million. The net proceeds of the financing will be used for general corporate purposes, including working capital, product development and capital expenditures, as well as for other strategic purposes.